Compare Align Technology, Inc. (ALGN) vs Royal Caribbean Cruises Ltd (RCL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Royal Caribbean Cruises Ltd — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Royal Caribbean Cruises Ltd trades at $283.99 (market cap $76.53B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 6× Align Technology, Inc.'s market cap, and Royal Caribbean Cruises Ltd pays a 1.75% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | RCL | |
|---|---|---|
Market Cap | $12.86B | $76.53B |
Sector | Health | Consumer Cyclical |
52-Week High | $207.19 | $365.84 |
52-Week Low | $124.88 | $246.71 |
Enterprise Value | $11.92B | $97.81B |
Dividend Yield | — | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Royal Caribbean (RCL) trades at $285.37, down 0.94% on the day, with a neutral technical signal and strong fundamental performance. The stock shows robust revenue growth, with 2025 revenue reaching $17.93 billion and net income of $4.27 billion, driving a high return on equity of 50.41%. Recent news highlights cruise industry momentum, including new ship experiences and a scheduled Q2 2026 earnings call on July 28, 2026.
Outlook remains positive given strong profitability and analyst consensus, with a price target of $328.00 implying 15% upside. Key risks include Europe demand weakness and high debt levels, though improving cash flow and Caribbean strength provide support. The stock presents a growth opportunity amid favorable industry trends, but investors should monitor execution on yield growth and cost management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →
